Funded Grants

PI Name PI Organization Title Grant Number Initiative Program Official Sort descending
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-02 Rachel Altshuler, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-02 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-02 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Buczynski, Matthew Wallace

Virginia Polytechnic Inst And St Univ
United States

Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy 1R01CA284075-01 Rachel Altshuler, Ph.D.
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 1R01CA275762-01A1 Rachel Altshuler, Ph.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Noble, Mark D

University Of Rochester
United States

Prevention and treatment of paclitaxel-induced peripheral neuropathy 5R21CA277447-02 Rachel Altshuler, Ph.D.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.
Khasabov, Sergey G

University Of Minnesota
United States

Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling 5R01CA263777-03 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-02 Rachel Altshuler, Ph.D.